Greenwich LifeSciences reports 33% increase in FLAMINGO-01 screening rate Mar 3, 2026 06:01AM
Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 Mar 3, 2026 06:00AM
Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026 Feb 24, 2026 06:01AM
Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026 Feb 24, 2026 06:00AM
Greenwich LifeSciences raises cash balance to $12.5 million through ATM Jan 27, 2026 06:00AM
View Older Stories

Jan 27, 2026 06:00AM Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy
Jan 22, 2026 06:00AM FDA approves Greenwich LifeSciences commercial GP2 for FLAMINGO-01 trial
Jan 22, 2026 06:00AM Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01
Dec 29, 2025 06:01AM Greenwich LifeSciences extends director lock-up to September 2026
Dec 29, 2025 06:00AM Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026
Dec 22, 2025 06:00AM Greenwich LifeSciences reports progress on FLAMINGO-01 breast cancer trial
Dec 22, 2025 06:00AM Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
Dec 15, 2025 06:01AM Greenwich LifeSciences reports 80% recurrence reduction in cancer trial
Dec 15, 2025 06:00AM Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01
Dec 8, 2025 06:02AM Greenwich LifeSciences completes enrollment in open label arm of phase III trial
Dec 8, 2025 06:00AM Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 
Dec 3, 2025 06:00AM Greenwich LifeSciences screens over 1,000 patients in phase III trial
Dec 3, 2025 06:00AM Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date
Oct 9, 2025 06:00AM Greenwich LifeSciences adds Austria to Phase III breast cancer trial
Oct 9, 2025 06:00AM Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
Oct 2, 2025 06:00AM Greenwich LifeSciences expands breast cancer trial to Belgium
Oct 2, 2025 06:00AM Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium
Sep 30, 2025 06:01AM Greenwich LifeSciences expands FLAMINGO-01 trial to Portugal
Sep 30, 2025 06:00AM Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial
Sep 18, 2025 06:01AM Greenwich LifeSciences expands breast cancer trial to Ireland
Sep 18, 2025 06:00AM Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland
Sep 10, 2025 06:00AM Greenwich LifeSciences gets FDA fast track status for breast cancer drug
Sep 10, 2025 06:00AM Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation
Aug 20, 2025 09:25AM Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences
Aug 19, 2025 06:01AM Greenwich LifeSciences builds internal clinical operations team
Aug 19, 2025 06:00AM Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team
Aug 13, 2025 06:00AM Greenwich LifeSciences expands breast cancer trial to Romania
Aug 13, 2025 06:00AM Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
Aug 11, 2025 06:00AM Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events
Aug 11, 2025 06:00AM Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events
Jun 27, 2025 09:00AM Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Apr 3, 2025 08:02AM Greenwich LifeSciences (GLSI) Provides Global Update on FLAMINGO-01
Apr 3, 2025 08:00AM Greenwich LifeSciences Provides Global Update on FLAMINGO-01
Apr 2, 2025 06:26AM Greenwich LifeSciences (GLSI) Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
Apr 2, 2025 06:00AM Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
Mar 27, 2025 06:00AM Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
Mar 17, 2025 06:45AM Greenwich LifeSciences (GLSI) Provides Update on Open Label Safety Data from FLAMINGO-01
Mar 17, 2025 06:45AM Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
Feb 10, 2025 06:00AM Greenwich LifeSciences (GLSI) Provides Update on Open Label HLA Data from FLAMINGO-01
Feb 10, 2025 06:00AM Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 
Jan 29, 2025 06:00AM Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe 
Jan 27, 2025 06:00AM Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
Jan 23, 2025 06:00AM Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 
Jan 22, 2025 06:03AM Greenwich LifeSciences (GLSI) Provides Update on Commercial Manufacturing
Jan 22, 2025 06:00AM Greenwich LifeSciences Provides Update on Commercial Manufacturing
Jan 14, 2025 06:15AM Greenwich LifeSciences (GLSI) Announces Partnership with GBG in Germany for Flamingo-01
Jan 14, 2025 06:15AM Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01
Jan 13, 2025 07:00AM Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France 
Nov 26, 2024 06:00AM Greenwich LifeSciences Partners with GIM in Italy
Nov 18, 2024 06:00AM Greenwich LifeSciences Provides Update on Corporate Events
View Older Stories